N@N

Ami Fadia Reiterated (BIIB) at Strong Buy and Held Target at $294 on, Jul 26th, 2024

Ami Fadia of Needham, Reiterated "Biogen Inc." (BIIB) at Strong Buy and Held Target at $294 on, Jul 26th, 2024.

Ami has made no other calls on BIIB in the last 4 months.

There are 11 other peers that have a rating on BIIB. Out of the 11 peers that are also analyzing BIIB, 5 agree with Ami's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $215 on, Thursday, April 25th, 2024
• Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $200 on, Thursday, April 25th, 2024
• Colin Bristow of "UBS" Maintained at Hold with Decreased Target to $214 on, Wednesday, April 17th, 2024
• Geoff Meacham of "B of A Securities" Maintained at Hold with Decreased Target to $260 on, Friday, April 12th, 2024
• Chris Schott of "JP Morgan" Maintained at Hold with Decreased Target to $240 on, Thursday, April 11th, 2024

These are the ratings of the 6 analyists that currently disagree with Ami

---

• Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $313 on, Friday, July 12th, 2024
• Brian Abrahams of "RBC Capital" Reiterated at Buy and Held Target at $317 on, Thursday, June 27th, 2024
• Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $300 on, Thursday, May 23rd, 2024
• Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy and Held Target at $340 on, Thursday, May 16th, 2024
• Morten Herholdt of "HSBC" Maintained at Strong Buy with Increased Target to $342 on, Friday, May 3rd, 2024
• Jay Olson of "Oppenheimer" Maintained at Buy and Held Target at $270 on, Monday, April 29th, 2024

Contributing Sources

---